Standard
WHO Drops Hydroxychloroquine and Lopinavir/Ritonavir Arms from Solidarity Trial for COVID-19 Treatment
The World Health Organization has officially accepted a crucial recommendation from the International Steering Committee of the Solidarity Trial to immediately discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir treatment arms. The global Solidarity Trial was originally established by the World Health Organization to find an effective, life-saving COVID-19 treatment specifically tailored for hospitalized patients battling the…
